[{"id":"567a1466-7f26-4ac5-a91a-ec368170ddfe","acronym":"","url":"https://clinicaltrials.gov/study/NCT05645601","created_at":"2022-12-09T14:57:52.982Z","updated_at":"2024-07-02T16:35:59.337Z","phase":"Phase 1","brief_title":"CAR-NK Targeted CD19 for r/r B-cell Malignancies","source_id_and_acronym":"NCT05645601","lead_sponsor":"Affiliated Hospital to Academy of Military Medical Sciences","biomarkers":" CD19","pipe":" | ","alterations":" CD19 expression","tags":["CD19"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e CD19 expression"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e cyclophosphamide • JD010"],"overall_status":"Recruiting","enrollment":" Enrollment 12","initiation":"Initiation: 12/01/2022","start_date":" 12/01/2022","primary_txt":" Primary completion: 05/30/2024","primary_completion_date":" 05/30/2024","study_txt":" Completion: 12/30/2024","study_completion_date":" 12/30/2024","last_update_posted":"2022-12-09"}]